Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.94 $3.83 Thursday, 9th May 2024 CLRB stock ended at $3.24. This is 1.25% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.36% from a day low at $3.18 to a day high of $3.25.
90 days $2.94 $4.45
52 weeks $1.36 $4.45

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
May 31, 2016 $3.35 $3.52 $3.12 $3.25 1 326 728
May 27, 2016 $3.15 $3.19 $3.00 $3.02 759 689
May 26, 2016 $3.45 $3.45 $3.08 $3.10 1 304 618
May 25, 2016 $3.78 $4.05 $3.30 $3.55 6 752 301
May 24, 2016 $3.75 $4.00 $3.03 $3.15 5 211 599
May 23, 2016 $3.43 $4.93 $3.03 $4.07 30 769 741
May 20, 2016 $1.06 $3.97 $1.06 $3.45 41 406 044
May 19, 2016 $1.18 $1.18 $1.00 $1.05 147 144
May 18, 2016 $1.29 $1.29 $1.08 $1.15 252 720
May 17, 2016 $1.37 $1.41 $1.15 $1.18 159 229
May 16, 2016 $1.40 $1.47 $1.35 $1.39 79 733
May 13, 2016 $1.55 $1.55 $1.38 $1.38 204 729
May 12, 2016 $1.49 $1.57 $1.36 $1.48 219 770
May 11, 2016 $1.40 $1.48 $1.36 $1.45 45 696
May 10, 2016 $1.47 $1.53 $1.36 $1.41 109 369
May 09, 2016 $1.55 $1.57 $1.42 $1.46 71 542
May 06, 2016 $1.60 $1.64 $1.50 $1.53 132 551
May 05, 2016 $1.72 $1.71 $1.60 $1.60 65 761
May 04, 2016 $1.77 $1.77 $1.55 $1.70 118 717
May 03, 2016 $1.76 $1.78 $1.70 $1.76 120 145
May 02, 2016 $1.63 $1.76 $1.63 $1.70 165 689
Apr 29, 2016 $1.84 $1.84 $1.61 $1.61 170 717
Apr 28, 2016 $1.76 $1.89 $1.76 $1.82 304 688
Apr 27, 2016 $1.84 $1.86 $1.75 $1.75 70 247
Apr 26, 2016 $1.97 $1.97 $1.76 $1.86 172 873
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT